2851 - 2875 of 6230 Results
Title
Year
- Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology2023OPENTitle: Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau PathologyJournal Name: Clinical ChemistryPublisher: Oxford University Press (OUP)Vol: 69Issue #: 11Start Page: 1247End Page: 1259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/clinchem/hvad139Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10895336Citation Count: 16
-
OPENTitle: A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 1Start Page: 117End Page: 129Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25274Citation Count: 60
-
OPENTitle: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241310722Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X241310722Citation Count: 1
- “Reply: Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long‐Term Health Outcomes in Parkinson's Disease Patients”2024OPENTitle: “Reply: Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long‐Term Health Outcomes in Parkinson's Disease Patients”Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14231Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11647979Citation Count: 0
- The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation2013OPENTitle: The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 233End Page: 240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.021Best OA location URL: https://portal.research.lu.se/files/1604585/4934203.pdfCitation Count: 19
- NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy2025OPENTitle: NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian EfficacyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.30175Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdf/10.1002/mds.30175Citation Count: 1
-
OPENTitle: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 139Issue #: 1Start Page: 76End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.13028Citation Count: 42
-
OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2539End Page: 2548Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28533Citation Count: 49
-
OPENTitle: Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 69End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.10.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9979781Citation Count: 17
- Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging2022OPENTitle: Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR ImagingJournal Name: American Journal of NeuroradiologyPublisher: American Society of Neuroradiology (ASNR)Vol: 43Issue #: 3Start Page: 354End Page: 360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3174/ajnr.a7410Best OA location URL: https://www.ajnr.org/content/ajnr/43/3/354.full.pdfCitation Count: 3
- Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning Approach2024OPENTitle: Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning ApproachJournal Name: BioengineeringPublisher: MDPI AGVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/bioengineering12010011Best OA location URL: https://www.mdpi.com/2306-5354/12/1/11/pdf?version=1735311941Citation Count: 0
- L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression2019OPENTitle: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/294951Citation Count: 27
- Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease2023OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 1End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/10543406.2023.2170400Citation Count: 7
- Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study2019OPENTitle: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3116End Page: 3128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz260Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3116/30063806/awz260.pdfCitation Count: 83
- Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates2020OPENTitle: Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primatesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aaz9165Best OA location URL: http://hdl.handle.net/11392/2420388Citation Count: 53
-
OPENTitle: A simulated annealing algorithm for randomizing weighted networksJournal Name: Nature Computational SciencePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43588-024-00735-zBest OA location URL: https://www.nature.com/articles/s43588-024-00735-z.pdfCitation Count: 0
-
OPENTitle: Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 98Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.27248Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.27248Citation Count: 0
- Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational efforts2017OPENTitle: Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational effortsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 140Issue #: 6Start Page: 1544End Page: 1547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx107Best OA location URL: https://academic.oup.com/brain/article-pdf/140/6/1544/18186427/awx107.pdfCitation Count: 18
-
OPENTitle: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinaseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 37Issue #: 1Start Page: 1End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201798099Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201798099Citation Count: 327
-
OPENTitle: LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 5Start Page: 1509End Page: 1525Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab073Best OA location URL: https://academic.oup.com/brain/article-pdf/144/5/1509/38813669/awab073.pdfCitation Count: 24
- Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)2022OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 10
- Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol2024OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12883-024-03702-3.pdfCitation Count: 5
- Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease2018OPENTitle: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s diseaseJournal Name: PeerJPublisher: PeerJVol: 6Issue #:Start Page: e5539End Page: e5539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7717/peerj.5539Best OA location URL: https://peerj.com/articles/5539.pdfCitation Count: 18
- Predicting Parkinson’s disease trajectory using clinical and functional MRI features: A reproduction and replication study2025OPENTitle: Predicting Parkinson’s disease trajectory using clinical and functional MRI features: A reproduction and replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e0317566End Page: e0317566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0317566Best OA location URL: https://doi.org/10.1371/journal.pone.0317566Citation Count: 0
-
OPENTitle: Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 23Start Page: 4465End Page: 4474Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00641Best OA location URL: https://research.vumc.nl/en/publications/e7a97383-cfe9-4b80-8b7c-80534b007972Citation Count: 22